Volume 40 Issue 10
Oct.  2024
Turn off MathJax
Article Contents
Luo GX,Li HS,Yuan ZQ,et al.No administering prophylactic systemic antibiotics routinely during the shock phase after burn injury[J].Chin J Burns Wounds,2024,40(10):911-914.DOI: 10.3760/cma.j.cn501225-20240809-00300.
Citation: Luo GX,Li HS,Yuan ZQ,et al.No administering prophylactic systemic antibiotics routinely during the shock phase after burn injury[J].Chin J Burns Wounds,2024,40(10):911-914.DOI: 10.3760/cma.j.cn501225-20240809-00300.

No administering prophylactic systemic antibiotics routinely during the shock phase after burn injury

doi: 10.3760/cma.j.cn501225-20240809-00300
Funds:

General Program of National Natural Science Foundation of China 82372515, 82072171

More Information
  • Corresponding author: Luo Gaoxing, Email: logxw@tmmu.edu.cn
  • Received Date: 2024-08-09
  • Infection is the most common complication following burn injury, while it is rare to induce immediately systemic infection after burn injury. Domestically, the burn patients especially the major burn patients are conventionally administered systemic antibiotics prophylactically during the shock phase after burn injury. However, the clinical evidences and all the international expert consensuses and guidelines on burn infections object strongly and clearly administration of systemic antibiotics prophylactically. The incidences of systemic infection and sepsis did not increase significantly after prohibiting prophylactical administration of systemic antibiotics routinely during the shock phase after burn injury based on the authors unit's clinical data of more than 100 major burn patients. Herein, we propose that the burn patients should not be routinely administered systemic antibiotics prophylactically during the burn shock phase.

     

  • loading
  • [1]
    LiH, ZhouJ, PengY, et al. The progress of Chinese burn medicine from the Third Military Medical University-in memory of its pioneer, Professor Li Ao[J/OL]. Burns Trauma, 2017,5:16[2024-08-09]. https://pubmed.ncbi.nlm.nih.gov/28573147/. DOI: 10.1186/s41038-017-0082-z.
    [2]
    JeschkeMG, van BaarME, ChoudhryMA, et al. Burn injury[J]. Nat Rev Dis Primers, 2020,6(1):11. DOI: 10.1038/s41572-020-0145-5.
    [3]
    KhalafF, RicciutiZ, BarayanD, et al. Post-burn endocrine-immune dynamics and ageing considerations[J]. Nat Rev Endocrinol, 2024,20(10):567-568. DOI: 10.1038/s41574-024-01018-3.
    [4]
    OsukaA, ShigenoA, MatsuuraH, et al. Systemic immune response of burns from the acute to chronic phase[J]. Acute Med Surg, 2024,11(1):e976. DOI: 10.1002/ams2.976.
    [5]
    LadhaniHA, YowlerCJ, ClaridgeJA. Burn wound colonization, infection, and sepsis[J]. Surg Infect (Larchmt), 2021,22(1):44-48. DOI: 10.1089/sur.2020.346.
    [6]
    GuF, HeW, ZhuD, et al. A 10-year retrospective study of methicillin-resistant Staphylococcus aureus from burn wound infection in southeast China from 2013 to 2022[J]. Front Microbiol, 2023,14:1301744. DOI: 10.3389/fmicb.2023.1301744.
    [7]
    WangY, LiQ, ShuQ, et al. Clinical epidemiology and a novel predicting nomogram of central line associated bloodstream infection in burn patients[J]. Epidemiol Infect, 2023,151:e90. DOI: 10.1017/S0950268823000766.
    [8]
    JeonK, HanSB, KymD, et al. Central venous catheter tip colonization and associated bloodstream infection in patients with severe burns under routine catheter changing[J]. Am J Infect Control, 2024,52(7):813-818. DOI: 10.1016/j.ajic.2024.02.003.
    [9]
    MaitzJ, MerlinoJ, RizzoS, et al. Burn wound infections microbiome and novel approaches using therapeutic microorganisms in burn wound infection control[J]. Adv Drug Deliv Rev, 2023,196:114769. DOI: 10.1016/j.addr.2023.114769.
    [10]
    DeyPK, GalibA, SardarA, et al. Nosocomial infection among burn patients admitted to a tertiary care hospital of Bangladesh: a cross-sectional study[J]. Ann Burns Fire Disasters, 2023,36(3):202-208.
    [11]
    PalmieriTL. Infection prevention: unique aspects of burn units[J]. Surg Infect (Larchmt), 2019,20(2):111-114. DOI: 10.1089/sur.2018.301.
    [12]
    罗高兴, 詹日兴, 袁志强, 等. 浅谈烧伤感染的分类与诊断命名[J].中华烧伤与创面修复杂志,2023,39(4):301-304. DOI: 10.3760/cma.j.cn501225-20221206-00528.
    [13]
    DellingerRP, CarletJM, MasurH, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004,32(3):858-873. DOI: 10.1097/01.ccm.0000117317.18092.e4.
    [14]
    EvansL, RhodesA, AlhazzaniW, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021,49(11):e1063-e1143. DOI: 10.1097/CCM.0000000000005337.
    [15]
    BoneRC, BalkRA, CerraFB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest,1992, 101(6):1644-1655. DOI: 10.1378/chest.101.6.1644.
    [16]
    SingerM, DeutschmanCS, SeymourCW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016,315(8):801-810. DOI: 10.1001/jama.2016.0287.
    [17]
    中华医学会烧伤外科学分会.中国烧伤年度报告2010-2016[M].2017.
    [18]
    TanJ, LiN, GongY, et al. Procalcitonin kinetics early after severe burn injury and its value in diagnosis of sepsis[J]. Burns, 2021,47(8):1802-1809. DOI: 10.1016/j.burns.2021.02.024.
    [19]
    ZhangYJ, GuoZH, MingZG, et al. Meta-analysis of the diagnostic value of serum procalcitonin for burn sepsis in adults[J]. Eur Rev Med Pharmacol Sci, 2023,27(15):7188-7200. DOI: 10.26355/eurrev_202308_33292.
    [20]
    BarayanD, AbdullahiA, VinaikR, et al. Interleukin-6 blockade, a potential adjunct therapy for post-burn hypermetabolism[J]. FASEB J, 2021,35(5):e21596. DOI: 10.1096/fj.202100388R.
    [21]
    HagerS, FoldenauerAC, RennekampffHO, et al. Interleukin-6 serum levels correlate with severity of burn injury but not with gender[J]. J Burn Care Res, 2018,39(3):379-386. DOI: 10.1097/BCR.0000000000000604.
    [22]
    GreenhalghDG, SaffleJR, 4thHolmes JH, et al. American Burn Association consensus conference to define sepsis and infection in burns[J]. J Burn Care Res, 2007,28(6):776-790. DOI: 10.1097/BCR.0b013e3181599bc9.
    [23]
    ISBI Practice Guidelines Committee, SubcommitteeSteering, SubcommitteeAdvisory. ISBI practice guidelines for burn care[J]. Burns, 2016,42(5):953-1021. DOI: 10.1016/j.burns.2016.05.013.
    [24]
    GreenhalghDG, HillDM, BurmeisterDM, et al. Surviving Sepsis After Burn Campaign[J]. Burns, 2023,49(7):1487-1524. DOI: 10.1016/j.burns.2023.05.003.
    [25]
    YinZ, BeiwenW, ZhenzhuM, et al. Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis[J]. Sci Rep, 2022,12(1):20105. DOI: 10.1038/s41598-022-24492-z.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (112) PDF downloads(23) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return